Pulmatrix Inc – Quartalsfinanzdaten (NASDAQ:PULM)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit -1.26 M-1.81 M-1.88 M-1.03 M-706 K -5.43 M Mittelzufluss aus Investitionstätigkeit 00000 0 Zahlungsströme aus der Finanzierungstätigkeit 0———— — Freier Cashflow -1.26 M-1.81 M-1.88 M-1.03 M-706 K -5.43 M

PULM

Financials

Nachrichten

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%

Pulmatrix merger with Cullgen terminated by Chinese firm

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.38%

Pulmatrix and Cullgen waive exclusivity while awaiting China approval

Kala Bio appoints Todd Bazemore as CEO and director, updates compensation

Pulmatrix (PULM) Q2 Revenue Falls 100%

Pulmatrix set for merger with Cullgen, seeks asset divestment